PP
LIVE

Serial Number

79425354

Owner

Paion Pharma GmbH

Attorney

Leigh Ann Lindquist

Filing Date

Apr 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PP Trademark

Serial Number: 79425354 • Registration: 8248637

PP is a trademark filed by Paion Pharma GmbH on April 2, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Paion Pharma GmbH (4 trademarks)

Heussstr. 25

Entity Type: 16

Trademark Details

Filing Date

April 2, 2025

Registration Date

May 12, 2026

Published for Opposition

March 24, 2026

Goods & Services

Chemicals, biological preparations, and biochemical preparations for use in industry and science; Chemicals for use in biotechnological manufacturing processes

Wholesale store services, retail store services, mail order services, online wholesale store services, and online retail store services featuring chemical, biological, and biochemical preparations for industrial, scientific, medical, veterinary and pharmaceutical purposes, and also featuring diagnostic preparations for medical purposes, reagents for medical purposes, vaccines, pharmaceutical preparations, and pharmaceuticals

Chemical and biochemical preparations for pharmaceutical or medical purposes for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Biological reagents for medical purposes; Biologics in the nature of pharmaceutical preparations for the treatment of for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Biochemical reagents for medical purposes; Diagnostic preparations for medical purposes; Reagents for medical purposes; Vaccines; Pharmaceutical preparations for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Sedatives; Anaesthetics; Hypnotics; Anxiolytics; Muscle relaxants; Anticonvulsants; Analgesics; Antibiotic preparations; Antiparasitics; Antihypertensives; Antihypotensives; Pharmaceutical preparations, namely, immunostimulants; Pharmaceutical preparations for gene therapy for the treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 27, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 27, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 27, 2026 CNEA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 21, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 21, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 21, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 21, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 21, 2026 COAR
REFUSAL PROCESSED BY IB
Nov 7, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 17, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2025 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jul 3, 2025 NREP
APPLICATION FILING RECEIPT MAILED
Jun 6, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 5, 2025 REPR